A chimeric virus passes through the blood-bran barrier and destroys brain tumors in mice, a new study reports.
Researchers conducting a clinical trial of Remdesivir to treat coronavirus report the drug appears to be promising. The drug, initially designed to treat Ebola, is well tolerated, and patients treated with the drug are showing signs of recovery. Early indications suggest Remdesivir could stave off the need for intubating patients suffering from COVID-19.
Virologist and computational neuroscientists agree, how humans treat and trade animals may have played a significant role in the coronavirus pandemic and other viral infections.